搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medical News Today
6 天
How might a Mediterranean diet affect inflammatory bowel disease?
Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...
Rolling Out
4 天
Mediterranean diet a promising strategy for managing inflammatory bowel disease
Inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis, affects millions of ...
1 天
on MSN
14 Things That Might Be Causing Pain in Your Lower Left Abdomen
Lower left abdominal pain can have many causes, ranging from minor to serious, says Andrew Boxer, M.D., gastroenterologist of ...
8 天
on MSN
Teva, Sanofi say bowel disease drug met primary targets (Dec 17)
Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping ...
Medscape
3 天
New Directions in Anemia and Related Disorders From ASH 2024
Strategies to reduce disease burden in alpha- or beta-thalassemia, sickle cell disease, and polycythemia vera, and insights into anemia in IBD, are among anemia highlights from ASH 2024.
3 天
How Bad Bacteria Hijack Your Gut and Trigger Painful Contractions
Researchers explored how Vibrio cholerae bacteria cause intense gut contractions through immune system activation, ...
9 天
Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug
Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 ...
Medscape
3 天
The Year in Gastroenterology: 10 Must-Read Studies
In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson ...
Yahoo Finance
10 天
Sanofi, Teva say study results show gut disease drug could be ‘best in class’
An experimental drug co-developed by Teva and Sanofi met its main objectives in a mid-stage clinical trial in inflammatory ...
centerforbiosimilars
1 天
The Top 5 Most-Read Conference Articles of 2024
The top 5 biosimilar conference articles in 2024 highlight significant progress in the biosimilar landscape, including ...
PMLiVE
9 天
Eli Lilly’s Omvoh recommended by CHMP to treat Crohn’s disease in adults
The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease ...
9 天
on MSN
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈